Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
WS

William L. Smith — 18 Patents

VIVivus: 8 patents #6 of 25Top 25%
AIA. H. Robins Company, Incorporated: 5 patents #13 of 80Top 20%
S(Syntex (U.S.A.): 3 patents #196 of 599Top 35%
WUWashington University: 2 patents #386 of 1,596Top 25%
Bristol-Myers Squibb: 2 patents #1,827 of 3,969Top 50%
Woodstock, NY: #3 of 111 inventorsTop 3%
New York: #7,989 of 115,490 inventorsTop 7%
Overall (All Time): #245,716 of 4,157,543Top 6%
18 Patents All Time
William L. Smith has been granted 18 US patents while listed as an inventor at Vivus. The first was granted in 1985 and the most recent in November 2023. William L. Smith ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list William L. Smith in Woodstock, NY, US.

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11813308 Treatment of cardiovascular disease using ActRII ligand traps Keith Hruska, Yifu Fang, Nianhang Chen 2023-11-14
10195249 Activin-ActRII antagonists and uses for treating bone and other disorders Victoria Sung, Randall Stevens, Victor Schorr Sloan, Keith Hruska, Yifu Fang 2019-02-05 $244,514,000
6548490 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2003-04-15 $2,445,000
6403597 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation Leland F. Wilson, Paul C. Doherty, Jr., Virgil A. Place, Ibrahim AbouBakr Abdel-Hamid Abdou Ali 2002-06-11 $4,148,000
6228864 Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation Paul C. Doherty, Jr., Virgil A. Place 2001-05-08 $3,079,000
6156753 Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2000-12-05 $3,759,000
6127363 Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2000-10-03 $6,263,000
6037346 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2000-03-14 $5,780,000
6037360 Administration of 5-HT.sub.3 receptor antagonists to treat premature ejaculation Paul C. Doherty, Jr., Virgil A. Place 2000-03-14 $5,780,000
5922341 Local administration of pharmacologically active agents to treat premature ejaculation Virgil A. Place 1999-07-13 $4,687,000
5202318 Tricyclic compounds acting at serotonin receptor subtypes Jacob Berger, Robin Clark, Richard Eglen, Klaus Weinhardt 1993-04-13 $18,116,000
5202333 Tricyclic 5-HT.sub.3 receptor antagonists Jacob Berger, Robin Clark, Richard Eglen, Klaus Weinhardt 1993-04-13 $18,116,000
5192770 Serotonergic alpha-oxoacetamides Robin Clark, Richard Eglen, Joseph M. Muchowski, Klaus Weinhardt 1993-03-09 $19,153,000
4863919 Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes 1989-09-05 $3,758,000
4857553 Method of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agents John Ward 1989-08-15 $3,712,000
4722834 Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs Lina C. Teng, Stephen C. Bearekman, Lennox B. Turnbull, Reevis S. Alphin 1988-02-02 $12,617,000
4717563 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs Reevis S. Alphin, Harry R. Munson, Jr., Robert F. Boswell, Jr. 1988-01-05 $10,924,000
4547514 Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity Pershottam P. Mathur 1985-10-15 $1,553,000